HK1209356A1 - Use of sutterella wadsworthensis in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of sutterella wadsworthensis in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209356A1
HK1209356A1 HK15110164.2A HK15110164A HK1209356A1 HK 1209356 A1 HK1209356 A1 HK 1209356A1 HK 15110164 A HK15110164 A HK 15110164A HK 1209356 A1 HK1209356 A1 HK 1209356A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
sutterella wadsworthensis
Prior art date
Application number
HK15110164.2A
Other languages
Chinese (zh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1209356A1 publication Critical patent/HK1209356A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK15110164.2A 2014-09-30 2015-10-16 Use of sutterella wadsworthensis in the treatment or prevention of rheumatoid arthritis or related diseases HK1209356A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522309.7A CN104546931B (en) 2014-09-30 2014-09-30 Magnificent moral Saudi Salmonella is treating or preventing the application in rheumatoid arthritis or its related disease

Publications (1)

Publication Number Publication Date
HK1209356A1 true HK1209356A1 (en) 2016-04-01

Family

ID=53064703

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110164.2A HK1209356A1 (en) 2014-09-30 2015-10-16 Use of sutterella wadsworthensis in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546931B (en)
HK (1) HK1209356A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US20070065817A1 (en) * 2002-05-09 2007-03-22 Sang-Yup Lee Nucleic acid probes for detection of non-viral organisms
AU2013359212B2 (en) * 2012-12-12 2017-01-19 Massachusetts Institute Of Technology Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation

Also Published As

Publication number Publication date
CN104546931B (en) 2019-04-09
CN104546931A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1244937A1 (en) Asset health scores and uses thereof
IL276690A (en) Neural microphysiological systems and methods of using the same
IL251529A0 (en) Use of cannabinoids in the treatment of epilepsy
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
IL251904B (en) Apilimod for use in the treatment of melanoma
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
GB201417163D0 (en) Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
PT3160464T (en) 6-hydroxybuspirone for use in the treatment of movement disorders
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
GB201404372D0 (en) Assay and treatment
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
IL252493A0 (en) Compounds for use in the prevention or treatment of cancer
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209367A1 (en) Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209364A1 (en) Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases